|
[1]
|
Gynecologic Oncology Expert Committee, Chinese Society of Clinical Oncology (2025) Expert Consensus on Diagnosis and Treatment of Neuroendocrine Carcinoma of the Cervix: 2025 Edition. Chinese Journal of Obstetrics and Gynecology, 60, 753-762.
|
|
[2]
|
Ren, X., Wu, W., Li, Q., Li, W. and Wang, G. (2023) Advances in Research, Diagnosis, and Treatment of Neuroendocrine Cervical Carcinoma: A Review. Oncology Reviews, 17, Article 11764. https://doi.org/10.3389/or.2023.11764
|
|
[3]
|
Wang, T., Zhang, L., Mei, S., Wang, B., Liu, J., Yang, W., et al. (2025) Single-Cell RNA Sequencing Highlights the Unique Tumor Microenvironment of Small Cell Neuroendocrine Cervical Carcinoma. Journal of Translational Medicine, 23, Article No. 19. https://doi.org/10.1186/s12967-024-05977-z
|
|
[4]
|
Lyu, Y.H., Liu, H.X., Han, X., Yuan, P., Wang, M.Y., He, Y.Y., et al. (2024) Clinicopathologic Characteristics and Prognostic Factors of Patients with Surgically Treated High‐Grade Neuroendocrine Carcinoma of the Cervix: A Multicenter Retrospective Study. International Journal of Gynecology & Obstetrics, 167, 1055-1065. https://doi.org/10.1002/ijgo.15771
|
|
[5]
|
Li, Q., Yu, J., Yi, H. and Lan, Q. (2022) Distant Organ Metastasis Patterns and Prognosis of Neuroendocrine Cervical Carcinoma: A Population-Based Retrospective Study. Frontiers in Endocrinology, 13, Article 924414. https://doi.org/10.3389/fendo.2022.924414
|
|
[6]
|
Bellone, S., Jeong, K., Halle, M.K., Krakstad, C., McNamara, B., Greenman, M., et al. (2024) Integrated Mutational Landscape Analysis of Poorly Differentiated High-Grade Neuroendocrine Carcinoma of the Uterine Cervix. Proceedings of the National Academy of Sciences of the United States of America, 121, e2321898121. https://doi.org/10.1073/pnas.2321898121
|
|
[7]
|
Lee, S.J., Lee, S., Nikas, I.P., Kim, M., Lee, M., Kim, H.S., et al. (2025) Clinical Significance of Different Histology and High-Risk HPV Types in Neuroendocrine Carcinomas of the Cervix. American Journal of Surgical Pathology, 49, 701-710. https://doi.org/10.1097/pas.0000000000002391
|
|
[8]
|
Park, S.M., Choi, C.H., Kim, K., Kim, H., Kim, S.I. and Lee, C.H. (2026) Cervical Neuroendocrine Carcinoma with Non-Neuroendocrine Components Has a Poorer Prognosis than Pure Neuroendocrine Carcinoma. Journal of Gynecologic Oncology, 37, e80. https://doi.org/10.3802/jgo.2026.37.e80
|
|
[9]
|
Mandic, A., Maksimovic, T., Nadj, G.S., Maricic, S. and Čelebić, A. (2025) Neuroendocrine Cervical Cancer: Have We Made Any Steps Forward in Its Management? European Journal of Surgical Oncology, 51, Article ID: 108570. https://doi.org/10.1016/j.ejso.2024.108570
|
|
[10]
|
Shen, T., Dong, T., Wang, H., Ding, Y., Zhang, J., Zhu, X., et al. (2025) Integrative Machine Learning Frameworks to Uncover Specific Protein Signature in Neuroendocrine Cervical Carcinoma. BMC Cancer, 25, Article No. 57. https://doi.org/10.1186/s12885-025-13454-z
|
|
[11]
|
Xiang, X., Tao, X., Hua, K., Jiang, H. and Ding, J. (2025) Single-Cell RNA Sequencing Reveals Tumor Heterogeneity in Small Cell Neuroendocrine Cervical Carcinoma. Communications Biology, 8, Article No. 184. https://doi.org/10.1038/s42003-025-07605-y
|
|
[12]
|
Chao, A., Wu, R.C., Lin, C.Y., Chang, T.C. and Lai, C.H. (2023) Small Cell Neuroendocrine Carcinoma of the Cervix: From Molecular Basis to Therapeutic Advances. Biomedical Journal, 46, Article ID: 100633. https://doi.org/10.1016/j.bj.2023.100633
|
|
[13]
|
Wang, X., Jia, W., Wang, M., Liu, J., Zhou, X., Liang, Z., et al. (2022) Human Papillomavirus Integration Perspective in Small Cell Cervical Carcinoma. Nature Communications, 13, Article No. 5968. https://doi.org/10.1038/s41467-022-33359-w
|
|
[14]
|
Kusakabe, M., Taguchi, A., Tanikawa, M., Wagatsuma, R., Yamazaki, M., Tsuchimochi, S., et al. (2022) Cells with Stem‐Like Properties Are Associated with the Development of HPV18‐Positive Cervical Cancer. Cancer Science, 114, 885-895. https://doi.org/10.1111/cas.15664
|
|
[15]
|
Masuda, M., Iida, K., Iwabuchi, S., Tanaka, M., Kubota, S., Uematsu, H., et al. (2024) Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix. The American Journal of Pathology, 194, 415-429. https://doi.org/10.1016/j.ajpath.2023.11.013
|
|
[16]
|
Kuji, S., Watanabe, R., Sato, Y., Iwata, T., Hirashima, Y., Takekuma, M., et al. (2017) A New Marker, Insulinoma-Associated Protein 1 (INSM1), for High-Grade Neuroendocrine Carcinoma of the Uterine Cervix: Analysis of 37 Cases. Gynecologic Oncology, 144, 384-390. https://doi.org/10.1016/j.ygyno.2016.11.020
|